The loss-of-function mutations in SEMA3E are formally associated with CHARGE syndrome, a complex multisystem genetic disease characterized by ocular coloboma, congenital heart defects, retardation of growth, genital hypoplasia, and facial asymmetry. Here, SEMA3E is linked to CHARGE syndrome.